Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)
A Randomized Trial of Electronic Integration of Care for Better Vascular Outcomes: The Compete III Study Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)
1 other identifier
interventional
1,000
1 country
1
Brief Summary
Vascular diseases (cardiac events, strokes, peripheral vascular disease) remain the number one killer in Canadian society as well as the leading cause of hospitalization and days spent in the hospital. A 1996 estimate placed Ontario's vascular disease financial burden at $5.5 billion in total. Any intervention which lowers vascular risk, will have a direct impact on the quantity and quality of life and costs of health care. Further integration of health professionals in teams focused on chronic disease management in individuals and populations is also ripe for further evaluation. Increased collaboration between family physicians, physician specialists, nurse practitioners, and pharmacists are generally thought to be beneficial for patient outcomes, but the literature is inconclusive and their cost-effectiveness is unproven. In addition, combining centralized electronic up-to-date information on the patient's status with evidence-based recommendations and the ability to communicate either electronically or by phone is expected to result in improved access to care, quality of care, continuity of care and increase cost-effectiveness of chronic disease management. COMPETE III builds on the researchers' previous work to study an electronic vascular tracking and decision support system shared by patients and their physicians, combined with a clinical care coordinator and automated telephone support system. The researchers are evaluating its impact on vascular risk processes and outcomes, perceived usefulness, ease of use, need for improvement, medication adherence, quality of life and patient goals and motivation. Study hypothesis: Patients at increased risk of vascular events, if connected with their family physicians, medical specialists and care coordinator via an electronic network (Web, fax and telephone) sharing an intensive tracking, advice and support program, will lower their vascular risk more than those in usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 17, 2005
CompletedFirst Posted
Study publicly available on registry
August 19, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedOctober 19, 2016
October 1, 2016
3.2 years
August 17, 2005
October 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The comparison of change in vascular monitoring process total score (proportion of process targets met in group) between intervention and control groups.
6 months to 1 year
Secondary Outcomes (9)
Vascular outcome targets
6 months to 1 year
Provider satisfaction, perceived value
6 months to 1 year
Patient satisfaction, self-efficacy, access to care
6 months to 1 year
Health data privacy and security
6 months to 1 year
Patient Quality of Life
6 months to 1 year
- +4 more secondary outcomes
Study Arms (1)
Intervention
OTHERBehavioural
Interventions
Eligibility Criteria
You may qualify if:
- years of age and over
- Regular patients of a family physician's office (at least one visit in the last 12 months)
- Vascular disease (previous myocardial infarction, stroke, peripheral vascular disease, coronary artery disease) or at least one of the following vascular risk factors (hypertension, hypercholesterolemia, diabetes)
You may not qualify if:
- Non-English speaking
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Evaluation of Medicines
Hamilton, Ontario, L8N 1G6, Canada
Related Publications (1)
Holbrook A, Pullenayegum E, Thabane L, Troyan S, Foster G, Keshavjee K, Chan D, Dolovich L, Gerstein H, Demers C, Curnew G. Shared electronic vascular risk decision support in primary care: Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III) randomized trial. Arch Intern Med. 2011 Oct 24;171(19):1736-44. doi: 10.1001/archinternmed.2011.471.
PMID: 22025430RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne M Holbrook, PharmD MD MSc
Centre for Evaluation of Medicines
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Division of Pharmacology & Toxicology
Study Record Dates
First Submitted
August 17, 2005
First Posted
August 19, 2005
Study Start
April 1, 2003
Primary Completion
June 1, 2006
Study Completion
June 1, 2006
Last Updated
October 19, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share